SCIACCA, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 7.238
AS - Asia 4.042
EU - Europa 4.024
SA - Sud America 736
AF - Africa 465
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 16.522
Nazione #
US - Stati Uniti d'America 6.945
SG - Singapore 2.022
RU - Federazione Russa 1.205
CN - Cina 1.081
IT - Italia 935
BR - Brasile 613
IE - Irlanda 577
UA - Ucraina 459
VN - Vietnam 316
CI - Costa d'Avorio 240
CA - Canada 229
DE - Germania 219
FR - Francia 208
KR - Corea 184
SE - Svezia 95
NG - Nigeria 94
IN - India 89
GB - Regno Unito 66
BD - Bangladesh 65
AR - Argentina 43
FI - Finlandia 41
SN - Senegal 40
PL - Polonia 36
MX - Messico 35
TR - Turchia 29
ID - Indonesia 28
HK - Hong Kong 26
ZA - Sudafrica 26
BE - Belgio 25
IR - Iran 24
CH - Svizzera 23
CZ - Repubblica Ceca 23
IQ - Iraq 23
JP - Giappone 22
NL - Olanda 22
UZ - Uzbekistan 22
AT - Austria 20
PK - Pakistan 19
CO - Colombia 18
EC - Ecuador 17
ES - Italia 17
VE - Venezuela 16
KE - Kenya 15
MY - Malesia 15
MA - Marocco 14
BJ - Benin 11
GR - Grecia 11
AU - Australia 10
CL - Cile 9
EG - Egitto 9
JM - Giamaica 9
LB - Libano 9
AE - Emirati Arabi Uniti 8
SA - Arabia Saudita 8
EU - Europa 7
JO - Giordania 7
PY - Paraguay 7
AZ - Azerbaigian 6
BO - Bolivia 6
LT - Lituania 6
PH - Filippine 6
TH - Thailandia 6
BA - Bosnia-Erzegovina 5
BG - Bulgaria 5
IL - Israele 5
NP - Nepal 5
RS - Serbia 5
ET - Etiopia 4
HN - Honduras 4
HR - Croazia 4
PE - Perù 4
RO - Romania 4
TT - Trinidad e Tobago 4
AO - Angola 3
BH - Bahrain 3
HU - Ungheria 3
NO - Norvegia 3
PT - Portogallo 3
TW - Taiwan 3
UY - Uruguay 3
CR - Costa Rica 2
DZ - Algeria 2
GA - Gabon 2
GE - Georgia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
SV - El Salvador 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
DO - Repubblica Dominicana 1
GM - Gambi 1
GT - Guatemala 1
IS - Islanda 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LV - Lettonia 1
Totale 16.515
Città #
Dallas 1.389
Singapore 1.134
Santa Clara 840
Dublin 565
Jacksonville 526
Moscow 504
Chandler 484
San Jose 462
Ashburn 313
Catania 291
Chicago 268
Boardman 253
Abidjan 240
Hefei 194
Seoul 184
Beijing 169
Lauterbourg 166
Nanjing 160
Cambridge 159
Lawrence 156
Andover 155
Toronto 146
Los Angeles 131
Des Moines 100
Ho Chi Minh City 96
Hanoi 84
Wilmington 82
Council Bluffs 80
Bremen 79
San Mateo 67
Civitanova Marche 65
New York 63
São Paulo 63
Nanchang 55
Grafing 52
Buffalo 49
Hebei 46
Shenyang 46
Munich 45
Lagos 44
Changsha 40
Dakar 40
Abuja 39
Saint Petersburg 39
Rome 37
Ottawa 32
Palermo 32
Tianjin 31
Quintano 30
Warsaw 30
Montreal 29
The Dalles 28
Jiaxing 27
Kochi 27
Columbus 26
Milan 26
Orem 26
Brussels 24
Hong Kong 22
Brooklyn 21
Tokyo 20
Lappeenranta 19
Denver 18
Seattle 18
Ardabil 17
Belo Horizonte 17
Rio de Janeiro 17
Stockholm 17
Atlanta 16
Haiphong 16
Houston 16
Brno 15
Ann Arbor 14
Falls Church 14
Phoenix 13
Da Nang 12
Dong Ket 12
Frankfurt am Main 12
Gravina di Catania 12
Helsinki 12
Jakarta 12
Johannesburg 12
Norwalk 12
Washington 12
Amsterdam 11
Cotonou 11
Messina 11
Port Harcourt 11
Pune 11
San Francisco 11
Tashkent 11
Avellino 10
Bronte 10
Chennai 10
Guangzhou 10
Redondo Beach 10
Turku 10
Brasília 9
Campinas 9
Izmir 9
Totale 11.130
Nome #
Sarcopenia in type 1 diabetes mellitus: a systematic review 444
Critical appraisal of the European Union Scientific Committee on Health, Environmental, and Emergency Risks (SCHEER) Preliminary Opinion on electronic cigarettes 218
Clinical appraisal of the European Union Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) Preliminary Opinion on electric cigarettes 207
La stimolazione con insulina o IGF-II delle isoforme A e B del recettore dell’insulina causa differenti effetti biologici in presenza di IRS-3 193
Body mass index is related to short term retinal worsening in type 2 diabetes patients treated with anticancer drugs 190
Cancer drugs and diabetic retinopathy: a dangerous, underestimated association 174
Combined use of sonographic and elastosonographic parameters can improve the diagnostic accuracy in thyroid nodules at risk of malignancy at cytological examination 160
Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels 155
Different Effects of the Insulin Receptor Isoforms on 32D Cell Growth and Differentiation 154
Effect of combined epigenetic treatments and ectopic NIS expression on undifferentiated thyroid cancer cells 150
Abnormal 1-hour post-load glycemia during pregnancy impairs post-partum metabolic status: a single-center experience 149
Do Nutrients and Nutraceuticals Play a Role in Diabetic Retinopathy? A Systematic Review 145
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.Cancer Res 144
Clinical Assessment of Altered Eating Behaviors in People with Obesity Using the EBA-O Questionnaire 144
Adipose tissue, obesity and adiponectin: Role in endocrine cancer risk 141
Efficacy of real-time glucose continuous glucose monitoring on glycaemic control and glucose variability in type 1 diabetic patients treated with either insulin pumps or multiple insulin injection therapy: a randomized controlled crossover trial 141
A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer 138
Comment on: Yang et al. (2010) Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry. Diabetes;59:1254-1260 135
Insulin receptor isoforms differently regulate cell proliferation and apoptosis in the ligand‐occupied and unoccupied state 135
Impact of unhealthy childhood and unfavorable parents' characteristics on adiposity in schoolchildren 131
Analoghi dell’insulina in gravidanza: Sono utili? Sono sicuri? 128
Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients 127
Short-term adverse effects of anticancer drugs in patients with type 2 diabetes 127
Associazione tra alterata tolleranza ai carboidrati e sindrome metabolica in gravidanza 125
Diabetes and Cancer 124
Computational modeling reveals MAP3K8 as mediator of resistance to vemurafenib in thyroid cancer stem cells 122
Biological effects of insulin and its analogs on cancer cells with different insulin family receptor expression 120
Insulin receptor isoforms in physiology and disease: An updated view 116
ASPB10 insulin, a super analog of insulin, causes an increased mitogenic response and phenotypic changes in human breast epithelial cells 115
Gestational Diabetes Mellitus pregnancy by pregnancy: early, late and nonrecurrent GDM 112
Type 2 Diabetic patients with Graves' Disease have more frequent and severe Graves’ orbitopathy 111
Efficacy of combined therapy with GLP1-RA and SGLT2-I in poorly controlled type 2 diabetes 110
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved 110
Efficacy of a phone reminder to improve adherence to post-partum glucose tolerance testing after gestational diabetes and clinical predictors of post-partum follow-up compliance 107
The novel loss of function Ile354Val mutation in PPARG causes familial partial lipodystrophy 106
Papillary Thyroid microcarcinomas: a comparative study of the characteristics and risk factors at presentation in two cancer registries 105
An observational study comparing Continous Subcutaneous Insulin Infusion (CSII) and insulin glargine in type 1 diabetes 105
The IGF system in thyroid cancer:new concepts 105
ASPB(10) insulin induction of increased mitogenic responses and phenotypic changes in human breast epithelial cells: Evidence for enhanced interactions with the insulin-like growth factor-I receptor 105
Associations between continuous glucose monitoring (CGM) metrics and psycholinguistic measures: a correlational study 104
Semaglutide: a game changer for metabolic diseases? 104
Diabete tipo 1 familiare e malattie autoimmuni extra-pancreatiche 103
Maternal Diabetes Impairs Insulin and IGF-1 Receptor Expression and Signaling in Human Placenta 103
Efficacia del Flash Glucose Monitoring in donne con diabete pregestazionale 102
Type I insulin-like growth factor receptor function in breast cancer 102
Infusione sottocutanea continua di insulina (CSII) e terapia insulinica multi-iniettiva (MDI) con glargine in pazienti con diabete mellito tipo 1 101
Insulin degludec in the first trimester of pregnancy: Report of two cases 101
COVID-19 vaccination in pregnant and lactating diabetic women 99
Influence of Body Mass Index, Cancer Type and Treatment on Long-Term Metabolic and Liver Outcomes in Childhood Cancer Survivors 99
Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group 98
Insulin receptor mediates the effects of the insulin–like growth factor II in breast cancer: a newly identified autocrine/paracrine loop 98
Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease 97
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer 96
Analoghi dell’insulina e cancro 96
Epigenetic mechanisms in type 2 diabetes retinopathy: A systematic review 96
Real-world efficacy of combination therapy with GLP1-RA and SGLT2-I in type 2 diabetes subjects with inadequate glucose control 95
IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation. 95
Insulin receptor isoforms in cancer 95
Efficacy of flash glucose monitoring in pregnant women with poorly controlled pregestational diabetes (FlashMom): A randomized pilot study 95
In IGF-I receptor-deficient leiomyosarcoma cells autcrine IGF-II induces cell cell invasion and protection from apoptosis via the insulin receptor isoform A 94
Continuous subcutaneous insulin infusion (CSII) vs multiple daily insulin injections (MDI) in type 1 diabetes: effects on blood glucose variability 93
Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism 93
Differential Gene Expression Induced by Insulin-like Growth Factor-II through the Insulin Receptor Isoform A 93
Efficacy of a phone reminder to improve adherence to post-partum OGTT after gestational diabetes 92
The isoform A of the insulin receptor as a regulator of the IGF system 92
Gestational diabetes and maternal-neonatal outcomes: importance of different OGTT alterations 92
Insulin and its analogs:actions via insulin and IGF receptors 91
Role of c-Abl in Directing Metabolic versus Mitogenic Effects in Insulin Receptor Signaling 91
Screening e diagnosi del diabete gestazionale. 90
Good blood glucose control three years after giving birth in diabetic women treated with continuous subcutaneous insulin infusion (CSII) during pregnancy 89
Screening e diagnosi di diabete gestazionale 89
Diabete e contraccezione 88
Use of insulin detemir in pregnancy: a report on 10 Type 1 diabetic women 88
Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells 88
Insulin-like growth factor II binds to and activate the insulin receptor isoform A in human fetal and cancer cells 87
Diagnosi di diabete gestazionale: istruzioni per l’uso 87
The automated correction index (ACI), a novel report-derived metric correlated to glucose control and variability in patients with type 1 diabetes on advanced hybrid closed loop therapy 86
IGF-II binding to insulin receptor isoform A induces a partially different gene expression profile from insulin binding 86
Insulin receptor A and B isoforms in 32D cells: signaling differences in the presence or absence of IRS-1 86
Signaling differences from the A and B isoforms of the insulin receptor in 32D cells in the presence or absence of IRS-1 86
Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling 85
Disordini del peso corporeo e del comportamento alimentare 85
Monitoraggio in continuo del glucosio (CGM) in donne con diagnosi di diabete gestazionale suddivise in base al BMI pregravidico 84
Obesity, insulin-resistance and cancer 83
Long-acting insulin analogs and cancer 83
Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway 83
Signaling Differences from the A and B isoforms of the Insulin Receptor (IR) in 32D Cells in the Presence or Absence of IR Substrate-1 82
Insulin receptors in breast cancer 82
Parametri predittivi per lo sviluppo del diabete mellito tipo 2 in donne con pregresso diabete gestazionale 81
Trattamento ipoglicemizzante e rischio di neoplasie 81
Screening of postpartum diabetes in women with gestational diabetes: high-risk subgroups and areas for improvements-the STRONG observational study 81
The insulin receptor isoform-A is a high affinity IGF-II receptor in human fetal cells 80
Studies of the purified fetal insulin receptor (IR-A) reveal that it is an IGF-II receptor 80
Risk for Coexistent Autoimmune Diseases in Familial and Sporadic Type 1 Diabetes is Related to Age at Diabetes Onset 80
Quality of Life, Wishes, and Needs in Women with Gestational Diabetes: Italian DAWN Pregnancy Study 79
Glicemia 1 h dopo carico orale di glucosio in donne normotolleranti con pregresso diabete gestazionale 79
Diabetes and cancer 79
Nuclear translocation of insulin receptor substrate-1 by the insulin receptor in mouse embryo fibroblasts 79
Efficacia del monitoraggio glicemico real-time sul compenso e sulla variabilità glicemica di pazienti con diabete mellito tipo 1 instabile 78
Screening and diagnosis of GDM: a new approach 78
Totale 11.110
Categoria #
all - tutte 57.096
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.164 142 164 10 18 187 9 174 42 97 0 45 276
2022/20231.776 175 47 20 235 154 328 1 293 413 21 56 33
2023/2024855 41 176 32 36 33 143 16 54 5 25 149 145
2024/20253.443 30 511 172 174 724 330 89 154 221 445 295 298
2025/20267.461 441 385 1.552 491 1.092 1.324 918 156 415 362 201 124
2026/202770 70 0 0 0 0 0 0 0 0 0 0 0
Totale 16.815